Reza Zadno Ph.D.
Net Worth

Last updated:

What is Reza Zadno Ph.D. net worth?

The estimated net worth of Dr. Reza Zadno Ph.D. is at least $44,546,615 as of 4 Dec 2024. He owns shares worth $6,044,792 as insider, has earned $37,196,223 from insider trading and has received compensation worth at least $1,305,600 in PROCEPT BioRobotics Corporation.

What is the salary of Reza Zadno Ph.D.?

Dr. Reza Zadno Ph.D. salary is $652,800 per year as Pres, Chief Executive Officer & Director in PROCEPT BioRobotics Corporation.

How old is Reza Zadno Ph.D.?

Dr. Reza Zadno Ph.D. is 70 years old, born in 1955.

What stocks does Reza Zadno Ph.D. currently own?

As insider, Dr. Reza Zadno Ph.D. owns shares in one company:

Company Title Shares Price per share Total value
PROCEPT BioRobotics Corporation (PRCT) Pres, Chief Executive Officer & Director 152,762 $39.57 $6,044,792

What does PROCEPT BioRobotics Corporation do?

PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aquablation therapy for males suffering from lower urinary tract symptoms due to BPH. As of December 31, 2021, it had an install base of 130 AquaBeam Robotic Systems worldwide comprising 78 in the United States. PROCEPT BioRobotics Corporation was incorporated in 2007 and is headquartered in Redwood City, California.

PRCT logo
PRCT
PROCEPT BioRobotics Corporation
$39.57

Reza Zadno Ph.D. insider trading

PROCEPT BioRobotics Corporation

Dr. Reza Zadno Ph.D. has made 19 insider trades between 2023-2024, according to the Form 4 filled with the SEC. Most recently he sold 13,762 units of PRCT stock worth $1,335,065 on 4 Dec 2024.

The largest trade he's ever made was exercising 288,461 units of PRCT stock on 30 Oct 2024. As of 4 Dec 2024 he still owns at least 152,762 units of PRCT stock.

Transaction Date Security Shares Price per share Total value Source
Sale
Common Stock 13,762 $97.01 $1,335,065
Sale
Common Stock 5,126 $98.09 $502,809
Sale
Common Stock 2,235 $99.04 $221,359
Sale
Common Stock 5,300 $96.15 $509,611
Sale
Common Stock 1,403 $99.96 $140,244
Sale
Common Stock 5,189 $99.24 $514,941
Sale
Common Stock 1,684 $98 $165,034
Sale
Common Stock 18,144 $97.25 $1,764,413
Sale
Common Stock 500 $93.88 $46,942
Sale
Common Stock 15,809 $92.82 $1,467,344
Sale
Common Stock 10,111 $92.12 $931,435
Sale
Common Stock 10,509 $92.74 $974,594
Sale
Common Stock 2,000 $93.64 $187,278
Sale
Common Stock 4,510 $95.58 $431,075
Sale
Common Stock 9,401 $94.95 $892,634
Sale
Common Stock 288,461 $91 $26,249,951
Option
Common Stock 288,461 $4.37 $1,260,575
Option
Stock Option (Right to Buy) 288,461 $4.37 $1,260,575
Option
Stock Option (Right to Buy) 23,484 $4.37 $102,625
Option
Common Stock 23,484 $4.37 $102,625
Sale
Common Stock 5,391 $48.83 $263,243
Sale
Common Stock 9,179 $46.67 $428,384
Option
Stock Option (Right to Buy) 5,148 $4.37 $22,497
Option
Common Stock 5,148 $4.37 $22,497
Option
Stock Option (Right to Buy) 19,995 $4.37 $87,378
Option
Common Stock 19,995 $4.37 $87,378
Option
Common Stock 20,022 $4.37 $87,496
Option
Stock Option (Right to Buy) 20,022 $4.37 $87,496
Sale
Common Stock 5,335 $31.84 $169,866

PROCEPT BioRobotics key executives

PROCEPT BioRobotics Corporation executives and other stock owners filed with the SEC: